Score Overview
Explore the 2021 public Archive ranking →
Where Enanta Pharmaceuticals Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ENTA
2018: 73.8% · 2021: 80.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-01 | $ 12.84 | — |
1 Year2025-10-01 | $ 10.61 | 21.02% |
5 Years2021-10-01 | $ 60.96 | -78.94% |
10 Years2016-09-30 | $ 26.61 | -51.75% |
All Time2013-03-21 | $ 17.18 | -25.26% |
| Period | Last Price2026-10-01 | 1 Year2025-10-01 | 5 Years2021-10-01 | 10 Years2016-09-30 | All Time2013-03-21 |
|---|---|---|---|---|---|
| Price | $ 12.84 | $ 10.61 | $ 60.96 | $ 26.61 | $ 17.18 |
| Return | — | 21.02% | -78.94% | -51.75% | -25.26% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 65M | -$ 63M | $ 189M |
| 2025 | $ 65M | -$ 81M | $ 188M |
| 2024 | $ 67M | -$ 116M | $ 248M |
| 2023 | $ 79M | -$ 133M | $ 369M |
| 2022 | $ 86M | -$ 121M | $ 249M |
| 2021 | $ 97M | -$ 78M | $ 244M |
| 2020 | $ 122M | -$ 36M | $ 386M |
| 2019 | $ 205M | $ 46M | $ 335M |
| 2018 | $ 206M | $ 71M | $ 308M |
| 2017 | $ 102M | $ 17M | $ 223M |
| 2016 | $ 88M | $ 21M | $ 210M |
| 2015 | $ 160M | $ 78M | $ 145M |
| 2014 | $ 47M | $ 34M | $ 90M |
| IPO2013 | $ 32M | $ 9M | $ 101M |
Enanta Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 122M to $ 65M and net income went from -$ 36M to -$ 81M. Revenue increased in 0 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 160M to $ 65M and net income went from $ 78M to -$ 81M. Revenue increased in 2 of those 10 years; net income in 4.
Enanta Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Membership
Continue ENTA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
